Home › Markets › Health Care › BJDX

Bluejay Diagnostics Inc. (BJDX)

BJDX trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$0.8323
+5.06% on the day
Market cap
$3.7M
Nano cap
Revenue
No annual revenue filed since the period ending 2022-12-31
Net income
No annual revenue filed since the period ending 2022-12-31

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerBJDX on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2021
SEC CIK0001704287
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials

No annual revenue filed since the period ending 2022-12-31.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS
424B32026-06-26
Latest annual report
ANNUAL REPORT
10-K2026-03-06
Latest quarterly / interim
QUARTERLY REPORT
10-Q2026-08-12
Latest current report
CURRENT REPORT
8-K2026-10-13
Latest proxy
PROXY STATEMENT
DEF 14A2026-04-30

Source: SEC EDGAR submissions feed, 248 recent filings. All filings on EDGAR.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
ICCMIceCure Medical Ltd.$1.10+1.85%$3.8M
ADGMAdagio Medical Holdings Inc$0.1253-5.08%$3.4M
IVFINVO Fertility Inc.$0.6399-11.86%$2.9M
VVOSVivos Therapeutics Inc.$0.1416-1.80%$4.8M
INBSIntelligent Bio Solutions Inc.$1.48-1.99%$4.9M
NVNOenVVeno Medical Corporation$7.97-2.21%$5.5M
SNOASonoma Pharmaceuticals Inc.$1.18-4.07%$5.7M
AMIXAutonomix Medical Inc.$3.01-2.90%$5.9M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier